Drug Shortage Report for MYLAN-BUDESONIDE AQ

Last updated on 2020-01-21 History
Report ID 23166
Drug Identification Number 02230648
Brand name MYLAN-BUDESONIDE AQ
Common or Proper name BUDESONIDE AQ
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) BUDESONIDE
Strength(s) 100MCG
Dosage form(s) SPRAY, METERED DOSE
Route of administration NASAL
Packaging size 165
ATC code R01AD
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-04-16
Actual start date 2018-04-16
Estimated end date 2020-01-30
Actual end date 2020-01-20
Shortage status Resolved
Updated date 2020-01-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v112 2019-03-28 French Compare
v111 2019-03-28 English Compare
v110 2019-02-01 French Compare
v109 2019-02-01 English Compare
v108 2019-01-18 French Compare
v107 2019-01-18 English Compare
v106 2019-01-15 French Compare
v105 2019-01-15 English Compare
v104 2018-12-19 French Compare
v103 2018-12-19 English Compare
v102 2018-11-20 French Compare
v101 2018-11-20 English Compare
v100 2018-10-09 French Compare
v99 2018-10-09 English Compare
v98 2018-09-24 French Compare
v97 2018-09-24 English Compare
v96 2018-09-10 French Compare
v95 2018-09-10 English Compare
v94 2018-07-09 French Compare
v93 2018-07-09 English Compare

Showing 21 to 40 of 132